Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisCsak meghívásosChemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
- Where
- Fuzhou
- Életkor
- 18 év and over
- People
- 35
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT06816966 - No phaseTaking peopleBiomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 50
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06818149 - No phaseTaking peopleSurvival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 800
- Run by
- Hunan Province Tumor Hospital
See details and how to joinNCT04324164 - 1. fázisTaking peopleEfficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
- Where
- Jilin City
- Életkor
- 18 év to 75 év
- People
- 144
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT05504278 - 2. fázisNot yet taking people in KínaNanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia
- Where
- Luoyang, Xinxiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 250
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06793228 - 2. fázisTaking peopleCadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 44
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06793813 - No phaseTaking peopleInvestigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients
- Where
- Suzhou
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- Zhao Jun
See details and how to joinNCT06790797 - No phaseNot yet taking people in KínaThe Impact of Thoracic Paravertebral Nerve Block At Different Positions on Pain Relief in Patients Undergoing Single-Port Thoracoscopic Partial Lung Resection
- Where
- Suzhou
- Életkor
- 18 év to 70 év
- People
- 200
- Run by
- Second Affiliated Hospital of Soochow University
See details and how to joinNCT06789276 - No phaseNot yet taking people in KínaReal-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure
- Where
- Zhengzhou
- Életkor
- 18 év and over
- People
- 55
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06786208 - 2. fázisNot yet taking people in KínaA Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer
- Where
- Fuzhou, Xiamen
- Életkor
- 18 év to 75 év
- People
- 34
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT06786312 - 4. fázisNot yet taking people in KínaEfficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma :A Multicenter, Real-World Clinical Study
- Where
- Fuzhou
- Életkor
- 18 év and over
- People
- 30
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT06785584 - No phaseTaking peopleArtificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 6000
- Run by
- Fudan University
See details and how to joinNCT06684418 - 2. fázisNot yet taking people in KínaAdebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06784206 - No phaseTaking peopleA Study on the Efficacy of Atezolizumab Combined with Chemotherapy
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 1430
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06780826 - 2. fázisNot yet taking people in KínaAdjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 70
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06780839 - No phaseTaking peopleLcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 2500
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06778512 - 1/2. fázisTaking peopleA Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 78
- Run by
- SUNHO(China)BioPharmaceutical CO., Ltd.
See details and how to joinNCT06581419 - 2. fázisTaking peopleA Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06775275 - No phaseTaking peopleEpidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
- Where
- Kunming
- Életkor
- 20 év to 90 év
- People
- 2000
- Run by
- First Affiliated Hospital of Kunming Medical University
See details and how to joinNCT06775821 - 2. fázisCsak meghívásosAdjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer
- Where
- Nanchang
- Életkor
- 18 év to 75 év
- People
- 37
- Run by
- Second Affiliated Hospital of Nanchang University
See details and how to joinNCT06773156 - No phaseTaking peopleDecoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach(Radiogenomics-Lung)
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 150
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06500312 - No phaseTaking peopleTo Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 60
- Run by
- Guangzhou Institute of Respiratory Disease
See details and how to joinNCT06772454 - 1. fázisTaking peopleA Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 48
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06768151 - No phaseNot yet taking people in KínaThe Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 60
- Run by
- Zhongnan Hospital
See details and how to joinNCT06768853 - 2. fázisTaking peopleA Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 28
- Run by
- Sichuan University
See details and how to joinNCT06769295